Levothyroxine Sodium Tablets recall (Major Pharmaceuticals)
DrugClass IIOngoing
Summary: Major Pharmaceuticals is recalling Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61. Reason: Subpotent Drug.
What is being recalled
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61
Why
Subpotent Drug
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
Nationwide in the USA.
How to tell if yours is affected
Lot# N02172, exp 07/2026; N02296, N02288, Exp. Date 12/2026
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0702-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | July 13, 2026 |
| Reported | July 29, 2026 |
| Company | Major Pharmaceuticals |
| Company location | Dublin, OH, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | N/A |
More recalls from Major Pharmaceuticals · all drug recalls · recalls from July 2026